Evidence map›Paper›PMID 32742262›Full record

ArticleFrontiers in pharmacology2020

Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety.

Joshua Silva, Amy S Shao, Yi Shen, Daryl L Davies, Richard W Olsen, Daniel P Holschneider, Xuesi M Shao, Jing Liang

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05280561 (Stress-, Anxiety-, and Cellphone Use-induced Sleep Deficits and Psychological Conditions During the Pandemic and a Potential Complementary Therapy), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05280561 nacompletednot on this mapstarted 2021, after this paper: background citation

Stress-, Anxiety-, and Cellphone Use-induced Sleep Deficits and Psychological Conditions During the Pandemic and a Potential Complementary Therapy

TypeinterventionalSponsorUniversity of Southern CaliforniaRan2021 to 2022Enrolled288ConditionsInsomnia Due to Anxiety and FearArmsDHM, Placebo
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Etiology of Dental Anxiety and Dental Phobia: Review.European journal of dentistry · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Disulfiram-Mitigating Unintended Effects.Antibiotics (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Joshua SilvaTitus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy, Los Angeles, CA, United States.
Amy S ShaoMolecular & Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Yi ShenDepartment of Neurobiology, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou, China.
Daryl L DaviesTitus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy, Los Angeles, CA, United States.
Richard W OlsenMolecular & Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Daniel P HolschneiderPsychiatry and The Behavioral Sciences, University of Southern California, Los Angeles, CA, United States.
Xuesi M ShaoNeurobiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Jing LiangTitus Family Department of Clinical Pharmacy, University of Southern California School of Pharmacy, Los Angeles, CA, United States.
University of Southern California · USUniversity of California, Los Angeles · USZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anxiety disorders are the most common mental illness in the U.S. and are estimated to consume one-third of the country's mental health spending. Although anxiolytic therapies are available, many patients exhibit treatment-resistance, relapse, or substantial side effects. An urgent need exists to explore the underlying mechanisms of chronic anxiety and to develop alternative therapies. Presently, we identified dihydromyricetin (DHM), a flavonoid that has anxiolytic properties in a mouse model of isolation-induced anxiety. Socially isolated mice demonstrated increased anxiety levels and reduced exploratory behavior measured by elevated plus-maze and open-field tests. Socially isolated mice showed impaired GABAergic neurotransmission, including reduction in GABA

Indexed as

anxietydihydromyricetin (DHM)GABAARgephyrinsocial isolation

Identifiers

PMID32742262
PMCPMC7364153
OpenAlexW3041208611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.